Health Product Shortages homepage

Welcome to Health Product Shortages Canada, the website for mandatory reporting of health product shortages and discontinuations by regulated parties. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the health products they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca (opens in new window).

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

List of shortage reports
Brand name Company Name Status Strength Update Date Updated View Report
ENHERTU ASTRAZENECA CANADA INC Actual shortage 100MG New Report 2025-12-03 257856
ARIMIDEX ASTRAZENECA CANADA INC Actual shortage 1MG Updated Report 2025-12-03 257848
JAMP-ANASTROZOLE JAMP PHARMA CORPORATION Actual shortage 1MG Updated Report 2025-12-02 246759
ANASTROZOLE SIVEM PHARMACEUTICALS ULC Actual shortage 1MG Updated Report 2025-12-02 217977
BREZTRI AEROSPHERE ASTRAZENECA CANADA INC Actual shortage 5MCG 160MCG 7.2MCG New Report 2025-12-02 257828
ARIMIDEX ASTRAZENECA CANADA INC Actual shortage 1MG New Report 2025-12-02 257825
LEVOFLOXACIN IN 5% DEXTROSE INJECTION HIKMA CANADA LIMITED Anticipated shortage 5MG Updated Report 2025-12-02 257816
PROLEUKIN IOVANCE BIOTHERAPEUTICS MANUFACTURING LLC Actual shortage 22000000UNIT Updated Report 2025-12-02 257813
FLUDARABINE PHOSPHATE INJECTION, USP ACCORD HEALTHCARE INC Actual shortage 25MG Updated Report 2025-12-02 247144
FLUDARABINE PHOSPHATE FOR INJECTION TEVA CANADA LIMITED Actual shortage 25MG New Report 2025-12-02 257575
ARIMIDEX ASTRAZENECA CANADA INC Actual shortage 1MG Updated Report 2025-12-01 257441
CARBOLITH BAUSCH HEALTH, CANADA INC. Resolved 300MG Updated Report 2025-12-01 232669
LITHANE SEARCHLIGHT PHARMA INC Actual shortage 300MG Updated Report 2025-12-01 228275
PMS-LITHIUM CARBONATE - CAP 300MG PHARMASCIENCE INC Actual shortage 300MG Updated Report 2025-12-01 207103
LITHANE SEARCHLIGHT PHARMA INC Actual shortage 150MG Updated Report 2025-12-01 227896
APO-LITHIUM CARBONATE APOTEX INC Resolved 300MG Updated Report 2025-12-01 227079
LITHMAX AA PHARMA INC Resolved 300MG Updated Report 2025-12-01 221857
!!T3 2% CALCIUM GLUCONATE IN SODIUM CHLORIDE INJECTION FRESENIUS KABI CANADA LTD Actual shortage 20MG Updated Report 2025-11-25 257411
ARIMIDEX ASTRAZENECA CANADA INC Actual shortage 1MG New Report 2025-11-25 257797
XYLOCAINE JELLY 2% ASPEN PHARMACARE CANADA INC. Actual shortage 20MG New Report 2025-11-22 257791

Discontinuation Reports

List of discontinuation reports
Brand name Company Name Status Strength Update Date Updated View Report
PRO-ANASTROZOLE PRO DOC LIMITEE Discontinued 1MG New Report 2025-12-03 257862
FASENRA ASTRAZENECA CANADA INC Discontinued 30MG New Report 2025-12-03 257859
ABIRATERONE JAMP PHARMA CORPORATION To be discontinued 250MG New Report 2025-12-03 257853
Galvin Howe MALLINCKRODT CANADA INC. Reversed Dolore fugiat cillum New Report 2025-12-03 257835
MYCOBUTIN PFIZER CANADA ULC Discontinued 150MG New Report 2025-12-02 257822
APO-RILUZOLE APOTEX INC To be discontinued 50MG New Report 2025-12-02 257819
!T3 APO-TICAGRELOR APOTEX INC To be discontinued 60MG New Report 2025-11-20 257700
!T3 BRILINTA ASTRAZENECA CANADA INC To be discontinued 90MG Updated Report 2025-11-20 257178
!!T3 APO-TICAGRELOR APOTEX INC Discontinued 60MG New Report 2025-11-20 257747
TEZSPIRE ASTRAZENECA CANADA INC To be discontinued 110MG New Report 2025-11-19 257744
IMFINZI ASTRAZENECA CANADA INC Discontinued 50MG Updated Report 2025-11-19 257688
2% CALCIUM GLUCONATE IN SODIUM CHLORIDE INJECTION FRESENIUS KABI CANADA LTD To be discontinued 20MG New Report 2025-11-16 257705
DOCETAXEL INJECTION ACCORD HEALTHCARE INC To be discontinued 20MG Updated Report 2025-11-15 257644
BREZTRI AEROSPHERE ASTRAZENECA CANADA INC Discontinued 5MCG 7.2MCG 160MCG New Report 2025-11-10 257657
FORXIGA ASTRAZENECA CANADA INC To be discontinued 10MG New Report 2025-10-31 257638
ENHERTU ASTRAZENECA CANADA INC To be discontinued 100MG New Report 2025-10-31 257632
FLUDARABINE PHOSPHATE FOR INJECTION TEVA CANADA LIMITED Discontinued 25MG Updated Report 2025-10-22 257579
(20MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP BAXTER CORPORATION To be discontinued 150MG 450MG 5G New Report 2025-10-14 257563
(20MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP BAXTER CORPORATION To be discontinued 150MG 450MG 5G New Report 2025-10-14 257560
BREZTRI AEROSPHERE ASTRAZENECA CANADA INC Discontinued 5MCG 7.2MCG 160MCG New Report 2025-10-11 257261
Get it on Google Play Download on the App Store